News
Purpose I look at the high frequency weekly indicators because while they can be very noisy, they provide a good nowcast of the economy,...
Hi, what are you looking for?
iFintechWorld
iFintechWorld
News
This article was written by Follow I am a value focused investor. Stocks rise and fall for many different reasons that we often cannot...
News
This article was written by Follow I’m an Equity Analyst and Accountant specializing in restaurant stocks, with a strong foundation in Business Administration and...
News
This article was written by Follow Investing in high-growth opportunities across industries, employing a value investing approach that prioritizes robust business models and strategic...
News
This article was coproduced with Dividend Sensei. It’s been years since NextEra Energy (NYSE:NEE) was finally reasonably priced or a good buy. FAST Graphs,...
News
By Breakingviews Alphabet (GOOG, GOOGL) is poised to welcome the autumn harvest. Ruth Porat, the web search giant’s chief financial officer and a former...
News
This article was written by Buy-side hedge professionals conducting fundamental, income oriented, long term analysis across sectors globally in developed markets. Please shoot us...
News
US The month started with a bang with the US jobs report but the following week is looking a little more subdued, starting with...
News
Overview ORLY stands as a prominent player in the automotive aftermarket industry in the United States. Renowned for its wide range of automotive parts,...
News
Thesis Banco BBVA Argentina (NYSE:BBAR) is one of the largest banks in Argentina. It is positioned to benefit from the ongoing digital transformation and...
News
Investment Thesis Nordstrom (NYSE:JWN) has undergone significant structural changes in its business model recently. We view these structural changes as a pivotal catalyst for...
News
JFrog (NASDAQ:FROG) provides clients with a supply chain software solution. The company has achieved a high amount of organic growth, but as the company...
News
Investment Briefing Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) is a biopharmaceutical company that specializes in developing and commercializing treatments for central nervous system (“CNS”) disorders. The...
